XOMAO (STOCKS)
XOMA Royalty Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock
$25.400000
-0.040000 (-0.16%)
Prev close: $25.440000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Owen Patrick Hughes
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $738.21M
- Employees
- 13
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.03 | $0.17 | -0.2034 | -117.30% |
|
Dec 2025 (Q4)
|
$0.26 | $-0.16 | +0.4181 | +264.45% |
|
Sep 2025 (Q3)
|
$0.70 | $-0.04 | +0.7408 | +1,815.69% |
|
Jun 2025 (Q2)
|
$0.44 | $-0.23 | +0.6651 | +295.47% |
Financial Statements
| Revenues | $48.56M |
| Benefits Costs and Expenses | $14.64M |
| Costs And Expenses | $14.64M |
| Operating Expenses | $43.58M |
| Research and Development | $468.00K |
| Other Operating Expenses | $43.11M |
| Operating Income/Loss | $4.98M |
| Income/Loss From Continuing Operations After Tax | $33.81M |
| Income/Loss From Continuing Operations Before Tax | $33.91M |
| Income Tax Expense/Benefit | $104.00K |
| Net Income/Loss | $33.81M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $33.81M |
| Net Income/Loss Available To Common Stockholders, Basic | $23.62M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $16.14M |
| Preferred Stock Dividends And Other Adjustments | $10.19M |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic | $8.27M |
| Basic Earnings Per Share | $1.65 |
| Diluted Earnings Per Share | $1.57 |
| Basic Average Shares | 12,006,000 |
| Diluted Average Shares | 17,618,000 |
| Assets | $271.86M |
| Current Assets | $118.75M |
| Noncurrent Assets | $153.11M |
| Fixed Assets | $18.00K |
| Intangible Assets | $43.86M |
| Other Non-current Assets | $109.23M |
| Liabilities | $158.96M |
| Current Liabilities | $33.08M |
| Accounts Payable | $3.53M |
| Other Current Liabilities | $29.54M |
| Noncurrent Liabilities | $125.89M |
| Redeemable Noncontrolling Interest | $20.02M |
| Redeemable Noncontrolling Interest, Preferred | $20.02M |
| Equity | $92.88M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $92.88M |
| Temporary Equity | $20.02M |
| Liabilities And Equity | $271.86M |
| Net Cash Flow From Operating Activities | $6.79M |
| Net Cash Flow From Operating Activities, Continuing | $6.79M |
| Net Cash Flow From Investing Activities | $64.13M |
| Net Cash Flow From Investing Activities, Continuing | $64.13M |
| Net Cash Flow From Financing Activities | -$27.21M |
| Net Cash Flow From Financing Activities, Continuing | -$27.21M |
| Net Cash Flow | $43.72M |
| Net Cash Flow, Continuing | $43.72M |
| Comprehensive Income/Loss | $33.81M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $33.81M |
| Other Comprehensive Income/Loss | $6.00K |